Title:
CDK INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2020/224568
Kind Code:
A1
Abstract:
Provided is a compound represented by structural formula (I), or a pharmaceutically acceptable salt, or a stereoisomer thereof useful for treating cancer.
Inventors:
HU ZHILONG (CN)
HE HU (CN)
ZHANG FEI (CN)
ZHU XIAOTIAN (US)
ZHONG WENGE (US)
HE HU (CN)
ZHANG FEI (CN)
ZHU XIAOTIAN (US)
ZHONG WENGE (US)
Application Number:
PCT/CN2020/088585
Publication Date:
November 12, 2020
Filing Date:
May 05, 2020
Export Citation:
Assignee:
QILU REGOR THERAPEUTICS INC (CN)
International Classes:
C07D471/04; A61K31/506; A61P35/00; C07D401/14
Domestic Patent References:
WO2010075074A1 | 2010-07-01 | |||
WO2016014904A1 | 2016-01-28 | |||
WO2016141881A1 | 2016-09-15 |
Other References:
See also references of EP 3966213A4
Attorney, Agent or Firm:
LIU, SHEN & ASSOCIATES (CN)
Download PDF: